Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133496) titled 'To analyze the risk factors of early leukopenia in patients with Graves' disease treated with methimazole and to construct and validate a nomogram prediction model' on Sept. 28.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First People's Hospital of Jingzhou
Condition:
Graves Disease
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-28
Target Sample Size: Observation group:800;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341966
Published by HT Digital Content Services with permission fr...